Wednesday, June 10, 2026
🇺🇸 FDA

Drug profile · INN

pneumococcal

pneumococcal is an FDA-listed pharmaceutical active ingredient.

NMPA: clinical trials
Patents linked 2
Pipeline programs 28
News articles 0
Drug details — pneumococcal
Class
—
Route
—
Patents
2
Programs
28
Data quality
0.70
← All drugs Related patents Pipeline programs Drug news hub Event calendar

Quick answer

pneumococcal is an FDA-listed pharmaceutical active ingredient.

Key facts

INN pneumococcal

Approval history

Authority Status Date
NMPA clinical trials —

Pipeline programs

Search pipeline
  1. 12-Valent Pneumococcal Conjugate Vaccine Phase 3 · MAIA Biotechnology · Pneumococcal Vaccines
  2. PCV21 Phase 3 · Sanofi Pasteur MSD · Pneumococcal Infections
  3. PCV21 vaccine Phase 3 · Sanofi Pasteur MSD · Pneumococcal Immunization
  4. PSK00010 Phase 3 · Sanofi-Aventis U.S · Pneumococcal immunisation
  5. PSK04 Phase 3 · Sanofi-Aventis U.S · Pneumococcal Immunization
  6. Prevnar 13™ Phase 3 · Merck KGaA, Darmstadt · Pneumococcal Infections
  7. Sinovac PCV13 Phase 3 · Sinovac Research and · Pneumococcal Infectious Diseases
  8. Sinovac PCV13 Phase 3 · Sinovac Research and · Pneumococcal Infectious Disease

Related patents

Browse patents

  1. US 8003112

    Meningococcal and pneumococcal conjugate vaccine and method of using same

    Expires Mon Aug 18 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 6312944

    Pneumococcal fimbrial protein A

    Expires Mon Nov 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

Frequently asked questions

What is pneumococcal?

pneumococcal is an FDA-listed pharmaceutical active ingredient.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.